Posted in Regulatory Accord, Intas, and Bio-Thera File Four IPRs Against Janssen Golimumab Patents March 27, 2026 Big Molecule Watch On March 20, 2026, Accord BioPharma, Inc. RegulatoryImmunology & InflammationRead full story